sciencenewsnet.in

Accure Acne Announces New FDA Clearance for the Long-Term Treatment of Acne

October 15, 2024 sarah JonasAnnouncement

Accure Acne, Inc.™ (www.accureacne.com), a pioneer in the development of innovative solutions for the treatment of acne, announced today that it has received a new FDA Clearance K242035 for the long-term treatment of mild to severe inflammatory acne vulgaris.

Koya Medical Announces Topline Results from Its Latest Trial on the Treatment of Lower Extremity Lymphedema at VENOUS2024

March 6, 2024 sarah JonasAnnouncement

Koya Medical, today announces topline results from its TEAYS trial. TEAYS (NCT05507346) is a prospective multi-center, randomized cross-over study comparing lower extremity lymphedema treatment effectiveness of Dayspring®, Koya’s non-pneumatic compression device (NPCD) with a traditional advanced pneumatic compression device (APCD).

Avails Medical Announces FDA Clearance of its eQUANT™ System to Accelerate Workflow for Antibiotic Susceptibility Testing

February 20, 2024 sarah JonasMarketplace

Avails Medical, Inc., a leader in the development of rapid, automated and fully electrical antibiotic susceptibility testing (AST) technologies, announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its groundbreaking eQUANTTM system.